Men and Women: Colorectal cancer risk: Elevated at 12%-20% Recommend colonoscopy every 1-2 years starting at age 20-25 Gastric cancer risk: Not well established Consider upper endoscopy every 3-5 years beginning at Permanent link to this article: ICARE Newsletter Winter 2020 Lynch Syndrome Cancer Risks Across Genes ICARE Newsletter Winter 2020 Lynch Syndrome Cancer Risks Across Genes A worldwide study reporting on cancer risks among individuals with mutations in Lynch syndrome genes showed that there are substantial differences in cancer risks across the various genes.1 Specifically, the risk for colorectal cancer in those with MLH1, MSH2, and MSH6 mutations was substantially higher than what was seen for those with PMS2 mutations
Ideally, talk with both: Your NEN specialist or oncologist, and The clinician who prescribes your GLP-1 drug Ask how your specific tumor type and overall health fit into whats known so far, and whether there are alternative options if needed
It is not available as a retail prescription drug
At 20C, ipamorelin retains full potency for 2436 months according to accelerated stability testing protocols published in the Journal of Pharmaceutical Sciences
Once deemed suitable, patients will receive a personalized weight management plan that includes GLP, dietary changes, and an exercise regimen
NAD injection Free virtual visit to discuss your goals Provider review to confirm you are a candidate Compounded NAD+ from a partner pharmacy if approved Discreet home delivery with clear instructions Simple plan, billed only when you reorder NAD for injection is a compounded product, not FDA approved for energy or aging, and is used under provider supervision
